GB202200885D0 - Nad-augmentation therapy for parkinson's disease - Google Patents

Nad-augmentation therapy for parkinson's disease

Info

Publication number
GB202200885D0
GB202200885D0 GBGB2200885.8A GB202200885A GB202200885D0 GB 202200885 D0 GB202200885 D0 GB 202200885D0 GB 202200885 A GB202200885 A GB 202200885A GB 202200885 D0 GB202200885 D0 GB 202200885D0
Authority
GB
United Kingdom
Prior art keywords
nad
parkinson
disease
augmentation therapy
augmentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2200885.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vestlandets Innovasjonsselskap AS
Original Assignee
Vestlandets Innovasjonsselskap AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestlandets Innovasjonsselskap AS filed Critical Vestlandets Innovasjonsselskap AS
Publication of GB202200885D0 publication Critical patent/GB202200885D0/en
Ceased legal-status Critical Current

Links

GBGB2200885.8A 2021-06-24 2022-01-24 Nad-augmentation therapy for parkinson's disease Ceased GB202200885D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2109138.4A GB202109138D0 (en) 2021-06-24 2021-06-24 NAD-augmentation Therapy for parkinson's disease

Publications (1)

Publication Number Publication Date
GB202200885D0 true GB202200885D0 (en) 2022-03-09

Family

ID=77179707

Family Applications (4)

Application Number Title Priority Date Filing Date
GBGB2109138.4A Ceased GB202109138D0 (en) 2021-06-24 2021-06-24 NAD-augmentation Therapy for parkinson's disease
GBGB2200885.8A Ceased GB202200885D0 (en) 2021-06-24 2022-01-24 Nad-augmentation therapy for parkinson's disease
GBGB2200883.3A Ceased GB202200883D0 (en) 2021-06-24 2022-01-24 Nad-augmentation therapy for parkinson's disease
GBGB2200884.1A Ceased GB202200884D0 (en) 2021-06-24 2022-01-24 NAD-augmentation therapy for Parkinson's disease

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB2109138.4A Ceased GB202109138D0 (en) 2021-06-24 2021-06-24 NAD-augmentation Therapy for parkinson's disease

Family Applications After (2)

Application Number Title Priority Date Filing Date
GBGB2200883.3A Ceased GB202200883D0 (en) 2021-06-24 2022-01-24 Nad-augmentation therapy for parkinson's disease
GBGB2200884.1A Ceased GB202200884D0 (en) 2021-06-24 2022-01-24 NAD-augmentation therapy for Parkinson's disease

Country Status (1)

Country Link
GB (4) GB202109138D0 (en)

Also Published As

Publication number Publication date
GB202109138D0 (en) 2021-08-11
GB202200884D0 (en) 2022-03-09
GB202200883D0 (en) 2022-03-09

Similar Documents

Publication Publication Date Title
EP3638315A4 (en) Aadc polynucleotides for the treatment of parkinson's disease
IL274648A (en) New catecholamine prodrugs for use in the treatment of parkinson's disease
PL2197883T3 (en) Catecholamine derivative useful for the treatment of parkinson's disease
EP3562514A4 (en) Gene therapy for treating wilson's disease
SG11202011296VA (en) Compositions and methods for the treatment of parkinson's disease
ZA202205344B (en) Gene therapy for alzheimer's disease
IL263188B (en) Treatment for parkinson's disease
EP4196113A4 (en) Pharmaceutical compositions and methods for treating parkinson's disease
IL278813A (en) Gene therapy for alzheimer's disease
EP3902539A4 (en) Methods for treating parkinson's disease by administering resiniferatoxin
AU2022299351A1 (en) Nad-augmentation therapy for parkinson's disease
EP3917502A4 (en) Methods of treating a patient having parkinson's disease
EP3998071A4 (en) Composition comprising o-cyclic phytosphingosine-1-phosphate for preventing or treating parkinson's disease
GB202016425D0 (en) Treatment regimens for parkinson's disease
SG11202102369VA (en) Compositions and methods for the treatment of parkinson's disease
IL288266A (en) Gene therapy for alzheimer's disease
GB202200884D0 (en) NAD-augmentation therapy for Parkinson's disease
IL309468A (en) Biomarkers for alzheimer's disease treatment
IL282562A (en) Composition and use for the treatment of parkinson's disease and related disorders
KR102467285B9 (en) Pharmaceutical Composition Comprising Woohuangchengsimhwan for Preventing or Treating Parkinson's Disease
EP4035669A4 (en) Preparation of drug for treating alzheimer's disease
GB201915753D0 (en) Alzheimer's disease
GB202212082D0 (en) Treatment regimens for parkinson's disease
EP4072568A4 (en) Methods for treating parkinson's disease
EP3943157A4 (en) Agent for treating parkinson's disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)